APA

Ramalingam S. S., Owonikoko T. K., Behera M., Subramanian J., Saba N. F., Kono S. A., Gal A. A., Sica G., Harvey R. D., Chen Z., Klass C. M., Shin D. M., Fu H., Sun S. R., Govindan R. & Khuri F. R. (20130730). Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chicago

Ramalingam Suresh S, Owonikoko Taofeek K, Behera Madhusmita, Subramanian Janakiraman, Saba Nabil F, Kono Scott A, Gal Anthony A, Sica Gabriel, Harvey R Donald, Chen Zhengjia, Klass Carmen M, Shin Dong M, Fu Haian, Sun Shi-yong R, Govindan Ramaswamy and Khuri Fadlo R. 20130730. Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Harvard

Ramalingam S. S., Owonikoko T. K., Behera M., Subramanian J., Saba N. F., Kono S. A., Gal A. A., Sica G., Harvey R. D., Chen Z., Klass C. M., Shin D. M., Fu H., Sun S. R., Govindan R. and Khuri F. R. (20130730). Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MLA

Ramalingam Suresh S, Owonikoko Taofeek K, Behera Madhusmita, Subramanian Janakiraman, Saba Nabil F, Kono Scott A, Gal Anthony A, Sica Gabriel, Harvey R Donald, Chen Zhengjia, Klass Carmen M, Shin Dong M, Fu Haian, Sun Shi-yong R, Govindan Ramaswamy and Khuri Fadlo R. Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 20130730.